|
1. |
Introduction |
|
Cerebrovascular Diseases,
Volume 7,
Issue 5,
1997,
Page 1-1
Julien Bogousslavsky,
Marc Fisher,
Preview
|
PDF (116KB)
|
|
ISSN:1015-9770
DOI:10.1159/000108266
出版商:S. Karger AG
年代:1997
数据来源: Karger
|
2. |
Progressing Stroke: Epidemiology |
|
Cerebrovascular Diseases,
Volume 7,
Issue 5,
1997,
Page 2-5
Åsa Rödén-Jüllig,
Preview
|
PDF (990KB)
|
|
ISSN:1015-9770
DOI:10.1159/000108267
出版商:S. Karger AG
年代:1997
数据来源: Karger
|
3. |
Acute Brain Infarction: Early Changes in Neurological Status |
|
Cerebrovascular Diseases,
Volume 7,
Issue 5,
1997,
Page 6-9
Geoffrey A. Donnan,
Helen Dewey,
Stephen M. Davis,
Amanda Thrift,
Preview
|
PDF (1076KB)
|
|
ISSN:1015-9770
DOI:10.1159/000108268
出版商:S. Karger AG
年代:1997
数据来源: Karger
|
4. |
Predictors of Stroke Deterioration |
|
Cerebrovascular Diseases,
Volume 7,
Issue 5,
1997,
Page 10-13
Danilo Toni,
Preview
|
PDF (1161KB)
|
|
ISSN:1015-9770
DOI:10.1159/000108269
出版商:S. Karger AG
年代:1997
数据来源: Karger
|
5. |
Recruitment of the Ischemic Penumbra into the Necrotic Core |
|
Cerebrovascular Diseases,
Volume 7,
Issue 5,
1997,
Page 14-18
Myron D. Ginsberg,
Ludmila Belayev,
Weizhao Zhao,
Preview
|
PDF (2145KB)
|
|
ISSN:1015-9770
DOI:10.1159/000108270
出版商:S. Karger AG
年代:1997
数据来源: Karger
|
6. |
Potential Mechanisms of Worsening |
|
Cerebrovascular Diseases,
Volume 7,
Issue 5,
1997,
Page 19-24
Antoni Dávalos,
José Castillo,
Preview
|
PDF (1825KB)
|
|
ISSN:1015-9770
DOI:10.1159/000108271
出版商:S. Karger AG
年代:1997
数据来源: Karger
|
7. |
Different Strokes in Different Folks: Unique Molecular Signatures of Cortical and Deep Brain Infarcts |
|
Cerebrovascular Diseases,
Volume 7,
Issue 5,
1997,
Page 243-244
Stephen G. Waxman,
Preview
|
PDF (438KB)
|
|
ISSN:1015-9770
DOI:10.1159/000108201
出版商:S. Karger AG
年代:1997
数据来源: Karger
|
8. |
Glutamate Is a Marker for Cerebral Ischemia in Cortical but Not Deep Infarcts |
|
Cerebrovascular Diseases,
Volume 7,
Issue 5,
1997,
Page 245-250
José Castillo,
Antoni Dávalos,
Manuela Lema,
Joaquín Serena,
Manuel Noya,
Preview
|
PDF (1091KB)
|
|
摘要:
We analyzed glutamate levels in cerebrospinal fluid (CSF) with respect to cerebral infarct topography in 67 patients with cortical infarcts and 78 with deep infarcts of less than 24 h duration. Infarct volume and topography were determined on repeated cerebral CT performed between 4 and 7 days after admission. Stroke severity was evaluated by the Canadian Stroke Scale (CSS) at 48 h after inclusion. Glutamate concentration in CSF was 8.4 ± 4.9 µmol/l in patients with cortical infarcts and 6.5 ± 5.2 µmol/l in patients with deep infarcts (p = 0.028). In cortical infarcts, glutamate levels correlated with the CSS score (Spearman coefficient –0.601, p < 0.001) and with the infarct volume (Spearman coefficient 0.671, p < 0.001). In the logistic regression analysis, glutamate was an independent predictor for stroke severity (high: CSS score < 5; low: CSS score ≧ 5) after controlling for age, inclusion delay, body temperature, glucose levels and fibrinogen (odds ratio = 1.3; 95% confidence interval= 1.07–1.67). Glutamate was not related significantly with the severity and size of deep cerebral infarcts. Early neurological deterioration was more frequent in cortical infarcts than in deep infarcts (43 vs. 19%, p < 0.001), and was independently related to glutamate levels in CSF. These results suggest that drugs that inhibit or antagonize glutamate may be useful particularly in cortical
ISSN:1015-9770
DOI:10.1159/000108202
出版商:S. Karger AG
年代:1997
数据来源: Karger
|
9. |
Quality of Hospital Care for Stroke Patients in The Netherlands |
|
Cerebrovascular Diseases,
Volume 7,
Issue 5,
1997,
Page 251-257
A. van Straten,
J.H.P. van der Meulen,
H. van Crevel,
J.D.F. Habbema,
M. Limburg,
Preview
|
PDF (1250KB)
|
|
摘要:
To assess the quality of some aspects of medical hospital care an explicit review instrument (a ''criteria map'') was developed on the basis of available evidence and consensus statements. The criteria are presented as ‘optimal care trajectories’, which depend on the patient''s clinical profile. The criteria map was applied in a study of 738 stroke patients over 45 years of age. We observed for 44% of the 738 studied patients one or more deviations from the optimal care trajectory with respect to at least one of five important aspects of medical care (CT scan, reversal of anticoagulation, treatment of hypertension, anti-platelet therapy, and evaluation of carotid arteries). The frequency of deviations from optimal care increased with patients'' age and level of disability. We conclude that the criteria map is a reliable tool for case-by-case review of the quality of c
ISSN:1015-9770
DOI:10.1159/000108203
出版商:S. Karger AG
年代:1997
数据来源: Karger
|
10. |
Cost-of-lllness Studies of Stroke |
|
Cerebrovascular Diseases,
Volume 7,
Issue 5,
1997,
Page 258-263
Vibeke Porsdal,
Gudrun Boysen,
Preview
|
PDF (1136KB)
|
|
摘要:
Stroke accounts for a significant proportion of the expenditures in the health care and social service sectors. Health economics studies of stroke have been performed in several countries. A selection of cost-of-illness studies of stroke from Europe, the USA and New Zealand were reviewed concerning methods of costing. The methodological differences between the studies are significant and this severely limits the possibility of comparing the results. Obtaining consensus on methodology is necessary to make future studies comparable.
ISSN:1015-9770
DOI:10.1159/000108204
出版商:S. Karger AG
年代:1997
数据来源: Karger
|
|